Smulevich Ab
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 18
- Psychosomatic Disorders and Their Treatments 14
- Bipolar Disorder and Treatment 6
- Electroconvulsive Therapy Studies 5
- Philosophy 20
- Mental Health and Psychiatry 20
- Co-authors
- Ferenc Martényi (4 shared papers)А С Аведисова (2 shared papers)Н. Г. Незнанов (2 shared papers)Bryan G. Johnson (1 shared paper)Lu Zhang (1 shared paper)L. M. Bardenstein (2 shared papers)Stephen L. Lowe (1 shared paper)Darryle D. Schoepp (1 shared paper)
- Journals
- European Neuropsychopharmacology (3 papers)Acta Dermato Venereologica (1 paper)Schizophrenia Bulletin (1 paper)Frontiers in Psychiatry (1 paper)Nature Medicine (1 paper)
- Partner nations
- RussiaUnited StatesGermany
In The Last Decade
Smulevich Ab
69 papers receiving 1.2k citations
Smulevich Ab's Hit Papers
Peers
Comparison fields: 5 of 81
- Biological Psychiatry 149
- Psychiatry and Mental health 463
- Cellular and Molecular Neuroscience 553
- Behavioral Neuroscience 34
- Cognitive Neuroscience 131
Countries citing papers authored by Smulevich Ab
This map shows the geographic impact of Smulevich Ab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smulevich Ab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smulevich Ab more than expected).
Fields of papers citing papers by Smulevich Ab
This network shows the impact of papers produced by Smulevich Ab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smulevich Ab. The network helps show where Smulevich Ab may publish in the future.
Co-authors
The 25 scholars most cited alongside Smulevich Ab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Hit paper breakdown → | 2007 | 793 |
| 2 | 2004 | 120 | |
| 3 | 2008 | 52 | |
| 4 | 2017 | 21 | |
| 5 | 2008 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 1989 | 17 | |
| 8 | 2001 | 13 | |
| 9 | 2017 | 11 | |
| 10 | 2018 | 11 | |
| 11 | 2019 | 10 | |
| 12 | [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. | 2008 | 9 |
| 13 | 2017 | 9 | |
| 14 | 2022 | 7 | |
| 15 | 2014 | 7 | |
| 16 | 2016 | 7 | |
| 17 | [Actual problems of systematics of depression]. | 2012 | 7 |
| 18 | 2015 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2015 | 6 |
About Smulevich Ab
Smulevich Ab is a scholar working on Psychiatry and Mental health, Philosophy, Clinical Psychology, Biological Psychiatry and Cellular and Molecular Neuroscience, having authored 73 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mental Health and Psychiatry (20 papers), Schizophrenia research and treatment (18 papers), Psychosomatic Disorders and Their Treatments (14 papers), Tryptophan and brain disorders (9 papers), Bipolar Disorder and Treatment (6 papers), Personality Disorders and Psychopathology (5 papers), Electroconvulsive Therapy Studies (5 papers) and Treatment of Major Depression (4 papers). The work is most often cited by research in Biological Psychiatry (149 citations), Psychiatry and Mental health (463 citations), Cellular and Molecular Neuroscience (553 citations), Behavioral Neuroscience (34 citations) and Cognitive Neuroscience (131 citations). Smulevich Ab has collaborated with scholars based in Russia, United States and Germany. Frequent co-authors include Ferenc Martényi, А С Аведисова, Н. Г. Незнанов, Bryan G. Johnson, Lu Zhang, L. M. Bardenstein, Stephen L. Lowe, Darryle D. Schoepp, Sergey Mosolov and В А Точилов. Their work appears in journals such as European Neuropsychopharmacology, Acta Dermato Venereologica, Schizophrenia Bulletin, Frontiers in Psychiatry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.